{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:01:08Z","timestamp":1790402468586,"version":"4.1.0"},"reference-count":73,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI\u2010EX113\u201011132HT"],"award-info":[{"award-number":["NHRI\u2010EX113\u201011132HT"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114\u20102314\u2010B\u2010038 \u2010062"],"award-info":[{"award-number":["114\u20102314\u2010B\u2010038 \u2010062"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["alz-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["A&amp;D Transl Res &amp; Clin Interv"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Vascular cognitive impairment (VCI), including vascular dementia (VaD), encompasses a spectrum of cognitive deficits resulting from cerebrovascular pathology, ranging from mild impairment to dementia. As the second leading cause of dementia worldwide, VCI remains a major therapeutic challenge. A comprehensive search of ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) identified randomized controlled trials (RCTs) conducted or completed between 2012 and 2025. Trials enrolling participants diagnosed with VCI or VaD across all disease stages and all trial phases were included. Forty\u2010one RCTs met the inclusion criteria encompassing diverse therapeutic mechanisms. Investigated agents included neuroprotective and vascular\u2010targeted compounds, neurotransmitter modulators, symptom\u2010focused drugs for behavioral and psychological symptoms of dementia (BPSD), traditional Chinese medicine (TCM) formulations, and agents acting on novel pathways. Recent trials in VCI and VaD show increasing methodological rigor and therapeutic diversity, signaling growing research momentum in the field. Nonetheless, progress is constrained by regional concentration of studies, limited publication of completed results, and inconsistent disease classification across stages. Strengthening global collaboration, ensuring transparent reporting, and standardizing disease staging will be critical to advancing pharmacological development for vascular cognitive disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/trc2.70293","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:40:30Z","timestamp":1784436030000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in pharmacotherapy for vascular cognitive impairment and vascular dementia: An update of 2025"],"prefix":"10.1002","volume":"12","author":[{"given":"Doan\u2010Khanh","family":"Tran","sequence":"first","affiliation":[{"name":"International Master Program in Medicine, College of Medicine Taipei Medical University  Taipei Taiwan"},{"name":"Tran Diep Khanh Medical Polyclinic  Ho Chi Minh City Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u2010Chun","family":"Kuan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Dementia Center, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Department of Neurology, School of Medicine, College of Medicine Taipei Medical University  Taipei Taiwan"},{"name":"Taipei Neuroscience Institute Taipei Medical University  Taipei Taiwan"},{"name":"Department of Biomedical Engineering National Taiwan University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li\u2010Kai","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Dementia Center, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Taipei Neuroscience Institute Taipei Medical University  Taipei Taiwan"},{"name":"Graduate Institute of Medical Neuroscience, College of Medical Science and Technology Taipei Medical University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaur\u2010Jong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Dementia Center, Shuang\u2010Ho Hospital Taipei Medical University  New Taipei Taiwan"},{"name":"Department of Neurology, School of Medicine, College of Medicine Taipei Medical University  Taipei Taiwan"},{"name":"Taipei Neuroscience Institute Taipei Medical University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311\u2010021\u201001170\u2010y"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000197886"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-54307-4_18"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.3"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.37897\/RJN.2019.1.2"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14186611"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/svn\u20102025\u2010004048"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911067"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929\u2010023\u201000976\u20106"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1415740"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.06.002"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221109454"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2015.01.042"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2019.0621"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00227"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1438926"},{"key":"e_1_2_11_18_1","unstructured":"First People's Hospital of Shenyang.Daphnetin Capsule in the Treatment of Vascular Cognitive Impairment Without Dementia.2025ClinicalTrials.gov Identifier NCT06507488."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106227"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00016804"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612733"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.25248\/reas.e12117.2023"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9949453"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150057"},{"key":"e_1_2_11_25_1","unstructured":"Charsire Biotechnology Corp.A Randomized Double\u2010Blind Vehicle\u2010Controlled Parallel Phase II Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia.2022. ClinicalTrials.gov Identifier NCT02886494"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3233\/jad\u2010221189"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd000147"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd005593"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013306.pub2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibra.12098"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub6"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.22062\/jkmu.2020.90614"},{"key":"e_1_2_11_33_1","unstructured":"LinCH.DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia.2018ClinicalTrials.gov Identifier NCT02103673"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2701526"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201002040\u20105"},{"key":"e_1_2_11_36_1","unstructured":"Chang Gung Memorial Hospital.Novel Augmentation of DAOIB and Antioxidant for Early Dementia.2026ClinicalTrials.gov Identifier NCT06467539."},{"key":"e_1_2_11_37_1","unstructured":"Chang Gung Memorial Hospital.DAOIB Combined With tDCS for Early\u2010phase Dementia: A Randomized Double\u2010blinded and Placebo Controlled Clinical Trial.2023ClinicalTrials.gov Identifier NCT04737096."},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.S234371"},{"key":"e_1_2_11_39_1","unstructured":"WebMD.Delta\u20109\u2010Tetrahydrocannabinol (THC)\u2014Uses Side Effects and More. Accessed November 11https:\/\/www.webmd.com\/vitamins\/ai\/ingredientmono\u20101690\/delta\u20109\u2010tetrahydrocannabinol\u2010thc#overview2025."},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2021.01.015"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1055\/a\u20102262\u20107837"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12121596"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.951889"},{"key":"e_1_2_11_44_1","doi-asserted-by":"crossref","unstructured":"PESSOA RMDP:Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: a randomized double\u2010blind placebo\u2010controlled trial. Doctoral thesis:UNIVERSIDADE DE S\u00c3O PAULO;2024.","DOI":"10.1017\/S1041610224002588"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953205"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010284.pub2"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000000289"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5012341"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.07.040"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673\u20105374.2013.19.001"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.04.010"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202412401182"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011\u2010200828090\u201000001"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.Cd003159"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/610103"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt\u20102015\u2010000365"},{"key":"e_1_2_11_57_1","unstructured":"Alzheimer's Drug Discovery Foundation.Pentoxifylline. Cognitive Vitality for Researchers.2019. Accessed November 11 2025.https:\/\/www.alzdiscovery.org\/uploads\/cognitive_vitality_media\/Pentoxifylline\u2010Cognitive\u2010Vitality\u2010For\u2010Researchers.pdf"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202412402169"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25126542"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.S334647"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010019\u20100064\u20107"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.2147\/cia.S58830"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1159\/000118805"},{"issue":"6","key":"e_1_2_11_64_1","first-page":"485","article-title":"Influence of piracetam and oxiracetam on the content of high\u2010energy phosphates and morphometry of astrocytes in vitro","volume":"51","author":"Gabryel B","year":"1999","journal-title":"Pol J Pharmacol"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1590\/1414\u2010431X20198371"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266\u2010018\u20100546\u20102"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1474\u20104422(18)30039\u20105"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034634"},{"key":"e_1_2_11_69_1","article-title":"Acadia Axes Antipsychotic Candidate After Phase III Schizophrenia Failure","author":"Manalac T","year":"2024","journal-title":"BioSpace"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub3"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967\u2010020\u201002232\u2010z"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202312307141"},{"key":"e_1_2_11_73_1","unstructured":"IranmaneshF.Comparison the Effects of Donepezil Galantamine Rivastigmine and Memantine on Vascular Dementia.2020. Iranian Registry of Clinical Trials Identifier IRCT20181210041912N1."},{"key":"e_1_2_11_74_1","unstructured":"ACADIA Pharmaceuticals Inc.A Double\u2010blind Placebo\u2010controlled Relapse Prevention Study of Pimavanserin for the Treatment of Hallucinations and Delusions Associated With Dementia\u2010related Psychosis.2018ClinicalTrials.gov Identifier NCT03325556."}],"container-title":["Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/trc2.70293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/trc2.70293","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/trc2.70293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:51:48Z","timestamp":1790401908000},"score":1,"resource":{"primary":{"URL":"https:\/\/alz-journals.onlinelibrary.wiley.com\/doi\/10.1002\/trc2.70293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/trc2.70293"],"URL":"https:\/\/doi.org\/10.1002\/trc2.70293","archive":["Portico"],"relation":{},"ISSN":["2352-8737","2352-8737"],"issn-type":[{"value":"2352-8737","type":"print"},{"value":"2352-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2025-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70293"}}